Algorae Pharmaceuticals (Algorae Pharmaceuticals) Common Stock : $54.57 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Algorae Pharmaceuticals Common Stock?

Algorae Pharmaceuticals's quarterly common stock increased from Dec. 2022 ($53.27 Mil) to Jun. 2023 ($53.85 Mil) and increased from Jun. 2023 ($53.85 Mil) to Dec. 2023 ($54.57 Mil).

Algorae Pharmaceuticals's annual common stock declined from Jun. 2021 ($56.86 Mil) to Jun. 2022 ($55.48 Mil) and declined from Jun. 2022 ($55.48 Mil) to Jun. 2023 ($53.85 Mil).

Algorae Pharmaceuticals Common Stock Historical Data

The historical data trend for Algorae Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Common Stock Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Common Stock

Get a 7-Day Free Trial

51.65

51.33

56.86

55.48

53.85

Algorae Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial															55.61	55.48	53.27	53.85	54.57

Algorae Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Algorae Pharmaceuticals (Algorae Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (OTCPK:LVCLY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

LVCLF:USA LHI0:Germany 1AI:Australia

Address

201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals (Algorae Pharmaceuticals) Headlines

From GuruFocus

Living Cell Technologies Ltd at Vertical Events Gold Coast Investment Showcase Transcript

By GuruFocus Research • 02-14-2024

Living Cell Technologies Ltd at Vertical Events Gold Coast Investment Showcase Transcript

By GuruFocus Research • 02-14-2024